Testing for Anaplastic Lymphoma Kinas (ALK) rearrangement is now recommended for selection of lung cancer patients targeted for Tyrosine-kinase inhibitors (Crizotimib). We used Fluorescence in situ hybridization (FISH) compared with Immunohistochemical (IHC) staining method to evaluate ALK gene rearrangement and ALK protein expression respectively in twenty cases of thoroughly diagnosed non-small cell lung cancer (NSCLC). The frequency and clinicopathological features of lung cancer harboring ALK rearrangement were reported. Results Histologically, 6 cases were adenocarcinoma and 14 were squamous cell carcinoma type. ALK IHC staining results was positive in 6 out of 20 (30%) using ALK/p80 (Clone SP8, Thermo scientific) monoclonal antibody. ALK rearrangement was detected in only 4 (20%) cases by FISH testing. Negative results were seen in the same 14 (70%) NSCLC cases by using both IHC and FISH techniques. Conclusion IHC may provide an effective strategy for detecting ALK gene changes, but it has false positive results necessitate further confirmatory FISH analysis which can be considered a gold standard method for ALK gene rearrangement detection. ALK gene rearrangement is highly associated with young aged men, non/light smokers and in those having more aggressive clinicopathological features.
Introduction
Lung carcinoma is the most common cancer and the most common cause of death from cancer worldwide with a ratio of mortality to incidence equal to 0.87 [1] . WHO classification (2015) proposed new criteria for lung cancer diagnosis depending on the cytology and biopsies [2] . These guidelines are important because most lung cancers are discovered in advanced stages [3] , so it is needed for an accurate pathological classification and molecular testing for specific therapies [4] .
Lung cancer is divided into small cell lung carcinoma and nonsmall cell lung carcinoma (NSCLC) histologically. NSCLCs represent ∼80% of all subtypes of lung cancer [5] . NSCLCs can be subclassified further into distinct histological subtypes including squamous cell carcinoma, adenocarcinoma, spindle cell, large-cell neuroendocrine carcinoma, and/or giant cell carcinoma and NSCLC-not otherwise specified [2] .
Systemic chemotherapy is the therapy of choice in most lung cancers to improve their outcome.
Progress in understanding the characterization of NSCLC by molecular typing helped in the study of therapeutic agents that target the common oncogenic mutations and evaluate the improvement response rates in patients with NSCLCs [6] .
The transmembrane protein anaplastic lymphoma kinase (ALK) receptor (a receptor tyrosine kinase anaplastic lymphoma, CD246), is one of the superfamily of insulin-like tyrosine kinase receptor, encoded by the ALK gene that located on chromosome 2 [7] . In NSCLCs the most frequent abnormality of the ALK gene is the inversion [Inv(2) (p21p23)] that occurs within the short arm of chromosome 2 leading to connection of the exons of echinoderm microtubule-associated protein-like 4 (EML4) and ALK gene and production of EML4-ALK fusion gene [8] .
As reported, NSCLC was sensitive to therapy with ALK tyrosine inhibitor (crizotinib), with a response rate of 57% and 6-month free survival rate of 72% [9] . So ALK molecular detection has become decisive for selecting the proper patients for target therapies.
Several methodologies can be used to detect EML4-ALK fusion, including real-time (RT) PCR, fluorescence in-situ hybridization (FISH), and immunohistochemistry (IHC) [10] . IHC is relatively economical and can be done in most diagnostic laboratories routinely [11] , whereas FISH has been shown to be sensitive and specific, but it needs specialized technical laboratories [12] .
The goal of this study is to study the frequency of ALK gene rearrangement by FISH technique compared with IHC staining method in NSCLC patients and to evaluate its clinicopathological significance in such cases.
Patients and methods
This prospective study was done on 20 patients from the Chest Department, Tanta University Hospitals during the period from September 2015 to December 2016, and diagnosed as NSCLC by clinical, radiological, and histological examination. There were 16 men and four women. Their age ranged from 40 to 77 years. NSCLC patients were diagnosed by cytological examination of bronchoavleolar lavage and pleural effusion cell block specimens followed by histological examination of tissue biopsy from the lung mass by fibreoptic biopsy or computed tomographic-guided biopsy. It was confirmed to be bronchogenic adenocarcinoma and squamous cell carcinoma by positive TTF1 and p63 immunostaining expression, respectively. Exclusion of neuroendocrine carcinoma is confirmed by negative chromogranin IHC expression.
All patients were passed through:
( ALK probe mixture measuring 10-15 μl was spotted onto the sample and cover slip was applied carefully and was sealed with rubber solution glue. Following this the slide was heated on the HyBrite surface (Vysis) at 78°C for 10 min to allow sample and probe denaturation and then the slide was cooled on the HyBrite surface (Vysis) to 37°C and left overnight for hybridization. Posthybridization washes: the slide was immersed in 0.4×SSC (pH: 7.0) at 74°C for 2 min, then drained and immersed in 2×SSCat RT (pH: 7.0) for 2 min. A measure of 15 μl of DAPI antifade was applied onto the sample with a cover slip on it and left in the dark for 10 min to develop the color; lastly the slides were examined with a fluorescence microscope.
The results of this study were statistically analyzed using the arithmetic mean, SD, Kruskal-Wallis H-test, Fisher's exact test, and Spearman's correlation.
Results

Clinicopathological and radiological results
The age of the patients under study ranged between 40 and 77 years with a mean value of 58.6±10.55. They were 16 (80%) men and four (20%) women. Thirteen (65%) of the cases were smokers and seven (35%) of the cases were nonsmokers.
Regarding the clinical data: 12 (60%) of the cases were complaining of dyspnea, 11(55%) had hemoptysis,12 (60%) had cough with expectoration. Eight (40%) of the cases were hypertensive and eight (40%) were diabetic. Eight patients had clubbing, 12 had lower limb edema, and rhonchi were auscultated in eight cases.
Radiological criteria of the studied cases: the size of the lesions (one dimension) ranged between 2 and 12 cm with a mean of 5.98±3.06, seven (35%) of the patients had lung collapse, two (10%) of the patients had consolidation, four (20%) had pleural effusion, and eight (40%) had hilar lymphadenopathy. Lung lesions were on the right side in 12 (60%) of the patients, on the left side in five (25%) of the patients, and bilateral in three (15%) patients. Eight (40%) of the patients had central tumor, six (30%) of the patients had cancer in the upper part of the lung, and six (30%) had cancer in the lower part (Diagram 2).
Cytological and histopathological examination of the tumors: 14 (70%) of the patients had squamous cell carcinoma and six (30%) of the patients had adenocarcinoma, two of them showed focal signet-ring cells (Fig. 1 ).
Immunohistochemical staining results
ALK gene protein expression was detected in six (30%) cases compared with 14 (70%) negative cases (Table 1) .
Diagram 2
Radiological criteria of the studied cases.
Among six adenocarcinoma cases, five (83.3%) of them were positive for ALK IHC expression and only one (16.7%) was negative. While among 14 squamous cell carcinoma cases, only one (7.1%) was positive and 13 (92.9%) cases were negative (Table 2 and Fig. 2 ).
Anaplastic lymphoma kinas gene detection results by fluorescence in-situ hybridization
Fourteen (70%) of the cases were normal, four (20%) of the cases had ALK gene rearrangement, and two (10%) of the cases had ALK gene polysomy (Diagram 3).
The relation between ALK gene rearrangement and histopathological type of the studied cases has shown that adenocarcinoma was prevailing in patients with ALK gene rearrangement compared with squamous cell carcinoma with statistically significant difference (P=0.037*) (Table 3 , Diagram 4, and Figs. 3-5).
As regards the smoking status, among the 13 smokers, 12 were normal, and one had ALK gene rearrangement. Among the seven nonsmoker cases, two showed normal ALK gene, three had ALK gene rearrangement, and two had ALK gene polysomy. There are significant statistical difference between smokers and nonsmokers regarding ALK gene rearrangement which is predominant in nonsmokers (P=0.012) ( Table 4 ).
The size of the lesions (sum of the largest diameters of the lesion in one dimension) ranged between 2 and 12 cm. In normal ALK gene group, the size ranged between 2 and 10 cm with a mean of 4.68±2.47. In patients with abnormal rearrangement, the size ranged between 6 and 10 cm with a mean value of 8.5±1.73. In cases with ALK gene polysomy, the size ranged between 8 and 12 cm with a mean value of 10±2.83. The lowest mean size was found in the normal group with statistically significant difference (P=0.026) ( Table 5 ). Correlation between anaplastic lymphoma kinas gene rearrangement and clinicopathological and radiological data There were significant negative correlation with age of the patients and significant positive correlations with different radiological criteria including the presence of pleural effusion, hilar lymphadenopathy, and size of the lesions, whereas no significant correlations were detected between ALK gene rearrangement and laboratory data except international normalized ratio (Table 6) .
Relation between immunohistochemical expression of anaplastic lymphoma kinas protein and anaplastic lymphoma kinas gene rearrangement using fluorescence in-situ hybridization technique
Among the six positive cases detected by IHC, rearrangement was detected only in four cases by using the FISH technique, whereas the remaining two positive cases showed normal ALK gene expression.
Discussion
Since the introduction of the ALK inhibitor (crizotinib) as an anticancer drug, ALK gene mutation testing is recommended for all NSCLCs to guide treatment [9] . An ideal true method to determine ALK gene has not been determined yet [13] . FISH was considered as a method of choice by Wu et al. [14] , because it is relatively simpler than other molecular techniques, and could detect all ALK rearrangements and is reliable and accurate. It also has the ability for visualizing translocation with specific probes for the ALK gene.
IHC for ALK protein expression has been found to be used for years in the diagnosis of anaplastic large-cell lymphoma, but these traditional antibodies used in lymphoma are not sensitive enough for the detection of ALK-rearranged lung cancers [15] .
Diagram 3
Anaplastic lymphoma kinas gene arrangement of the studied cases by fluorescence in-situ hybridization. ALK, anaplastic lymphoma kinas. It has been reported by Conde et al. [16] that in addition to convenient and economical advantage, IHC methods can detect both known and unknown ALK gene changes at the ALK protein level. However, Hutarew et al. [17] reported that the antibodies often did not show excellent sensitivity and specificity since the ALK protein was expressed at lower levels. Therefore, the optimal clinical method for ALK gene rearrangement identification in tissue samples remains to be elucidated.
Diagram 4
Histopathological type of the studied cases according to anaplastic lymphoma kinas gene arrangement by fluorescence in-situ hybridization. ALK, anaplastic lymphoma kinas.
Figure 3
Poorly differentiated bronchogenic squamous cell carcinoma showing strong granular cytoplasmic and nuclear positivity for ALK immunostain (Streptavidin Biotin ×200).
Figure 4
Interphase cells of adenocarcinoma patient show ALK gene rearrangement.
So the goal of this study was to study the frequency of ALK gene mutations by FISH technique in comparison to IHC staining in NSCLC patients and evaluate their clinicopathological significance.
As regards ALK gene mutation by FISH in this study, 14 (70%) patients had normal ALK gene, four (20%) patients had ALK gene rearrangement, and two (10%) patients had polysomy. This ALK gene detection results is more or less similar to that reported by Wang et al. [18] , who detected ALK gene mutation in six of the 22 studied cases (27.2%) of lung cancer.
Another study done by Krawczyk et al. [19] reported that the normal ALK gene was observed in 36.62%, ALK gene polysomyin in 35.21%, ALK gene amplification without arrangement in 4.2%, and ALK gene rearrangement was observed in 2.82%, and 21.13% of samples were not interpretable in lung cancer patients.
A comparison between FISH and IHC results showed that ALK IHC protein expression in this study get a higher positive rate than FISH. Among the six ALK +IHC cases, rearrangement was detected only in four cases by FISH. At the same time, all the remaining 14 cases showed negative results in both IHC and FISH analyses. These results denote that the IHC technique may give false-positive results, but it can be considered as a good negative screening test. The higher positive rate in IHC detection could be explained by the fact that IHC is to detect protein expression regardless of how the ALK gene changes [20] .
Another study compared IHC, FISH, and RT-PCR in the detection of ALK gene mutation, indicated high sensitivity and specificity of RT-PCR in detecting EML4-ALK mutation, but remains inadequate screening test for detecting ALK+. It can give high false negative results due to the specificity of the probe [21] . Moreover, Pekar-Zlotin et al. [22] indicated that ALK IHC screening in his study should be strongly considered as the FISH method in the detection of Figure 5 Interphase cells of squamous cell lung cancer patient show ALK gene polysomy. ALK, anaplastic lymphoma kinas; *P<0.05, significant. EML4-ALK rearrangement may miss a significant number of patients who may get a benefit from targeted ALK therapy.
ALK gene rearrangement in relation to age and sex in this study revealed that rearrangement can be presented with lung cancer in younger patients than those with normal ALK gene. Also, ALK gene rearrangement was detected in men more than women, but the difference was statistically insignificant.
In agreement with our results, Sholl et al. [23] demonstrated that ALK gene rearrangement was significantly more common in young patients, but more common in women than men, whereas Shaw et al. [24] observed that ALK gene mutations are frequent in men.
The present study detected that ALK gene rearrangement was significantly more common in nonsmoking lung cancer patients than smoking patients. This is in agreement with Tan et al. [25] who reported that the prevalence of ALK gene mutations is higher in nonsmokers than smokers or in those with past history of smoking. However, another study stated that there was no significant difference between smokers' and nonsmokers' tumors regarding abnormal ALK gene [26] .
As regards radiological lesions in this study, ALK gene abnormalities were mainly detected in patients with advanced lung cancer with large size, bilateral lesions, and lesions associated with hilar lymphadenopathy and pleural effusion. This is in agreement with Yamamoto et al. [27] who detected that ALK+ status was associated with large pleural effusion and Halpenny et al. [28] who found that ALK-positive lung adenocarcinomas were more likely to be associated with larger sized tumors.
It has been reported that patients with ALK+ were mostly presented by advanced disease at the time of diagnosis, which reflect the tumors aggressiveness and their tendency for cerebral and hepatic metastases in addition to pleural and pericardial effusions [29] . Another published study detected that tumors with ALK rearrangement showed lymphangitic spread such as advanced lymphadenopathy, lymphangitic carcinomatosis, and pericardial or pleural metastasis [30] . However, Wen et al. [31] observed that there was no significant association between ALK fusion gene and lung cancer stage.
The present study detected significant difference between normal and abnormal ALK gene patients regarding tumor histopathology. Many patients (66%) with abnormal ALK gene had adenocarcinoma, whereas squamous cell carcinoma was detected mainly in patients with normal ALK gene. In agreement with these results, Tan et al. [25] detected solid adenocarcinoma in more than 40% of abnormal ALK gene rearranged patients.
Another study said that the majority of adenocarcinomas NSCLCs were ALK+ whereas only few cases of squamous cell carcinoma showed ALK+ [26] . 
Conclusion
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